Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials.

BMJ · 2012 · PMC3496553 · PMID 23150473

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

All of the novel oral anticoagulants (except in the small apixaban study) showed a trend towards lower rates of major bleeding compared with vitamin K antagonists, but this was significant only for rivaroxaban.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.